| 1 |
Anzarut A, Olson J, Singh P, et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 2009;62:77-84.
DOI
|
| 2 |
Sadeghinia A, Sadeghinia S. Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg 2012;38:104-9.
DOI
|
| 3 |
Ogawa R, Akaishi S, Huang C, et al. Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 2011;78:68-76.
DOI
|
| 4 |
Schrementi ME, Ferreira AM, Zender C, et al. Site-specific production of TGF-beta in oral mucosal and cutaneous wounds. Wound Repair Regen 2008;16:80-6.
DOI
|
| 5 |
Huang C, Akaishi S, Hyakusoku H, et al. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J 2014;11:517-22.
DOI
|
| 6 |
Kupietzky A, Levi-Schaffer F. The role of mast cell-derived histamine in the closure of an in vitro wound. Inflamm Res 1996;45:176-80.
DOI
|
| 7 |
Gauglitz GG, Bureik D, Dombrowski Y, et al. Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol 2012;25:313-8.
DOI
|
| 8 |
Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg 2005;31:1394-8.
DOI
|
| 9 |
Cacao FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg 2009;35:629-33.
DOI
|
| 10 |
Edwards L. The interferons. Dermatol Clin 2001;19:139-46.
DOI
|
| 11 |
Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 2006;8:362-8.
DOI
|
| 12 |
Lee JH, Kim SE, Lee AY. Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol 2008;47:183-6.
DOI
|
| 13 |
Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002;110:560-71.
DOI
|
| 14 |
Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998;40:490-3.
DOI
|
| 15 |
Clark CP, Vanderpool D, Preskitt JT. The response of retroperitoneal fibrosis to tamoxifen. Surgery 1991;109:502-6.
|
| 16 |
Gold MH, McGuire M, Mustoe TA, et al. Updated international clinical recommendations on scar management: part 2: algorithms for scar prevention and treatment. Dermatol Surg 2014;40:825-31.
|
| 17 |
Huang C, Ogawa R. Roles of lipid metabolism in keloid development. Lipids Health Dis 2013;12:60.
DOI
|
| 18 |
Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg 2008;206:731-41.
DOI
|
| 19 |
Wong TW, Chiu HC, Chang CH, et al. Silicone cream occlusive dressing: a novel noninvasive regimen in the treatment of keloid. Dermatology 1996;192:329-33.
DOI
|
| 20 |
Hosnuter M, Payasli C, Isikdemir A, et al. The effects of onion extract on hypertrophic and keloid scars. J Wound Care 2007;16:251-4.
DOI
|
| 21 |
Bell L, McAdams T, Morgan R, et al. Pruritus in burns: a descriptive study. J Burn Care Rehabil 1988;9:305-8.
DOI
|
| 22 |
Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with Dermojet injections of bleomycin: a preliminary study. Int J Dermatol 2005;44:777-84.
DOI
|
| 23 |
Payapvipapong K, Niumpradit N, Piriyanand C, et al. The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color. J Cosmet Dermatol 2015;14:83-90.
DOI
|
| 24 |
Perdanasari AT, Lazzeri D, Su W, et al. Developments in the use of intralesional injections keloid treatment. Arch Plast Surg 2014;41:620-9.
DOI
|
| 25 |
Meaume S, Le Pillouer-Prost A, Richert B, et al. Management of scars: updated practical guidelines and use of silicones. Eur J Dermatol 2014;24:435-43.
DOI
|
| 26 |
Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1: evaluating the evidence. Dermatol Surg 2014;40:817-24.
|
| 27 |
Lv K, Xia Z; Chinese consensus panel on the prevention and treatment of scars. Chinese expert consensus on clinical prevention and treatment of scar. Burns Trauma 2018;6:27.
DOI
|
| 28 |
Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997;37:755-7.
DOI
|
| 29 |
Ogawa R, Akita S, Akaishi S, et al. Diagnosis and treatment of keloids and hypertrophic scars-Japan Scar Workshop Consensus Document 2018. Burns Trauma 2019;7:39.
|
| 30 |
Hochman B, Locali RF, Matsuoka PK, et al. Intralesional triamcinolone acetonide for keloid treatment: a systematic review. Aesthetic Plast Surg 2008;32:705-9.
DOI
|
| 31 |
Bijlard E, Steltenpool S, Niessen FB. Intralesional 5-fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol 2015;95:778-82.
|
| 32 |
Macintyre L, Baird M. Pressure garments for use in the treatment of hypertrophic scars: a review of the problems associated with their use. Burns 2006;32:10-5.
DOI
|
| 33 |
Goldenberg G, Luber AJ. Use of intralesional cryosurgery as an innovative therapy for keloid scars and a review of current treatments. J Clin Aesthet Dermatol 2013;6:23-6.
|
| 34 |
Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 2017;43 Suppl 1:S3-18.
DOI
|
| 35 |
Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001;27:23-7.
DOI
|
| 36 |
Shin JY, Yun SK, Roh SG, et al. Efficacy of 2 representative topical agents to prevent keloid recurrence after surgical excision. J Oral Maxillofac Surg 2017;75:401.
|
| 37 |
Ho WS, Ying SY, Chan PC, et al. Use of onion extract, heparin, allantoin gel in prevention of scarring in Chinese patients having laser removal of tattoos: a prospective randomized controlled trial. Dermatol Surg 2006;32:891-6.
DOI
|
| 38 |
Fette A. Influence of silicone on abnormal scarring. Plast Surg Nurs 2006;26:87-92.
DOI
|
| 39 |
Ripper S, Renneberg B, Landmann C, et al. Adherence to pressure garment therapy in adult burn patients. Burns 2009;35:657-64.
DOI
|
| 40 |
Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg 2008;32:82-92.
DOI
|
| 41 |
de Oliveira GV, Nunes TA, Magna LA, et al. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg 2001;27:721-6.
DOI
|
| 42 |
Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg 2002;110:177-83.
DOI
|
| 43 |
Bayat A, McGrouther DA, Ferguson MW. Skin scarring. BMJ 2003;326:88-92.
DOI
|
| 44 |
Kikuchi K, Kadono T, Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology 1995;190:4-8.
DOI
|
| 45 |
Mari W, Alsabri SG, Tabal N, et al. Novel insights on understanding of keloid scar: article review. J Am Coll Clin Wound Spec 2016;7:1-7.
DOI
|
| 46 |
Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003;4:235-43.
DOI
|
| 47 |
Juckett G, Hartman-Adams H. Management of keloids and hypertrophic scars. Am Fam Physician 2009;80:253-60.
|
| 48 |
Poetschke J, Gauglitz GG. Current options for the treatment of pathological scarring. J Dtsch Dermatol Ges 2016;14:467-77.
|
| 49 |
Wilson AM. Eradication of keloids: surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin. Can J Plast Surg 2013;21:87-91.
DOI
|
| 50 |
Huang C, Liu L, You Z, et al. Managing keloid scars: from radiation therapy to actual and potential drug deliveries. Int Wound J 2019;16:852-9.
DOI
|
| 51 |
Arno AI, Gauglitz GG, Barret JP, et al. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns 2014;40:1255-66.
DOI
|
| 52 |
Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest 1998;78:47-58.
|
| 53 |
Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17:113-25.
DOI
|
| 54 |
Love PB, Kundu RV. Keloids: an update on medical and surgical treatments. J Drugs Dermatol 2013;12:403-9.
|
| 55 |
Wolfram D, Tzankov A, Pulzl P, et al. Hypertrophic scars and keloids: a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009;35:171-81.
DOI
|
| 56 |
Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 2007;31:468-92.
DOI
|
| 57 |
Robles DT, Moore E, Draznin M, et al. Keloids: pathophysiology and management. Dermatol Online J 2007;13:9.
|
| 58 |
Khan MA, Bashir MM, Khan FA. Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc 2014;64:1003-7.
|
| 59 |
Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002;204:130-2.
DOI
|
| 60 |
Jones CD, Guiot L, Samy M, et al. The use of chemotherapeutics for the treatment of keloid scars. Dermatol Reports 2015;7:5880.
|
| 61 |
Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004;30:54-6.
DOI
|
| 62 |
Crooke ST, Bradner WT. Bleomycin, a review. J Med 1976;7:333-428.
|
| 63 |
Bakker A, Maertens KJ, Van Son MJ, et al. Psychological consequences of pediatric burns from a child and family perspective: a review of the empirical literature. Clin Psychol Rev 2013;33:361-71.
DOI
|
| 64 |
Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 2009;34:219-23.
DOI
|
| 65 |
Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg 2014;67:1017-25.
DOI
|
| 66 |
Bailey JN, Waite AE, Clayton WJ, et al. Application of topical mitomycin C to the base of shave-removed keloid scars to prevent their recurrence. Br J Dermatol 2007;156:682-6.
DOI
|
| 67 |
Danielsen PL, Rea SM, Wood FM, et al. Verapamil is less effective than triamcinolone for prevention of keloid scar recurrence after excision in a randomized controlled trial. Acta Derm Venereol 2016;96:774-8.
|
| 68 |
O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63-78.
DOI
|
| 69 |
Sherris DA, Gassner HG. Botulinum toxin to minimize facial scarring. Facial Plast Surg 2002;18:35-9.
DOI
|
| 70 |
Ardekani GS, Aghaie S, Nemati MH, et al. Treatment of a postburn keloid scar with topical captopril: report of the first case. Plast Reconstr Surg 2009;123:112e-113e.
DOI
|
| 71 |
Wu CS, Wu PH, Fang AH, et al. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Br J Dermatol 2012;167:532-41.
DOI
|
| 72 |
Akita S, Akino K, Yakabe A, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg 2007;18:1164-9.
DOI
|
| 73 |
Sclafani AP, Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg 1996;22:569-74.
DOI
|
| 74 |
Mourad B, Elfar N, Elsheikh S. Spray versus intralesional cryotherapy for keloids. J Dermatolog Treat 2016;27:264-9.
DOI
|
| 75 |
Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg 1996;37:167-9.
DOI
|
| 76 |
El-Kamel MF, Selim MK, Alghobary MF. Keloidectomy with core fillet flap and intralesional verapamil injection for recurrent earlobe keloids. Indian J Dermatol Venereol Leprol 2016;82:659-65.
DOI
|
| 77 |
Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg 2003;29:1050-1.
DOI
|
| 78 |
van Leeuwen MC, Stokmans SC, Bulstra AE, et al. Surgical excision with adjuvant irradiation for treatment of keloid scars: a systematic review. Plast Reconstr Surg Glob Open 2015;3:e440.
DOI
|
| 79 |
Gupta S, Kumar B. Intralesional cryosurgery using lumbar puncture and/or hypodermic needles for large, bulky, recalcitrant keloids. Int J Dermatol 2001;40:349-53.
DOI
|
| 80 |
Levy DS, Salter MM, Roth RE. Postoperative irradiation in the prevention of keloids. AJR Am J Roentgenol 1976;127:509-10.
DOI
|
| 81 |
Keeling BH, Whitsitt J, Liu A, et al. Keloid removal by shave excision with adjuvant external beam radiation therapy. Dermatol Surg 2015;41:989-92.
DOI
|
| 82 |
Shen J, Lian X, Sun Y, et al. Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions. J Radiat Res 2015;56:811-7.
DOI
|
| 83 |
McKeown SR, Hatfield P, Prestwich RJ, et al. Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Br J Radiol 2015;88:20150405.
DOI
|
| 84 |
Xiao Z, Zhang F, Cui Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report. Aesthetic Plast Surg 2009;33:409-12.
DOI
|
| 85 |
Occleston NL, O'Kane S, Laverty HG, et al. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring. Wound Repair Regen 2011;19 Suppl 1:s38-48.
DOI
|
| 86 |
Berman B, Harrison-Balestra C, Perez OA, et al. Treatment of keloid scars post-shave excision with imiquimod 5% cream: a prospective, double-blind, placebo-controlled pilot study. J Drugs Dermatol 2009;8:455-8.
|
| 87 |
Hochman B, Isoldi FC, Furtado F, et al. New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects. Clin Cosmet Investig Dermatol 2015;8:67-73.
DOI
|
| 88 |
Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol 2008;74:343-8.
DOI
|
| 89 |
Kim A, DiCarlo J, Cohen C, et al. Are keloids really "gliloids"? High-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol 2001;45:707-11.
DOI
|
| 90 |
Lee KK, Mehrany K, Swanson NA. Surgical revision. Dermatol Clin 2005;23:141-50.
DOI
|
| 91 |
Viera MH, Caperton CV, Berman B. Advances in the treatment of keloids. J Drugs Dermatol 2011;10:468-80.
|
| 92 |
Iannello S, Milazzo P, Bordonaro F, et al. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid: two case reports and literature review. MedGenMed 2006;8:60.
|
| 93 |
D'Andrea F, Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology 2002;204:60-2.
DOI
|
| 94 |
Aggarwal A, Ravikumar BC, Vinay KN, et al. A comparative study of various modalities in the treatment of keloids. Int J Dermatol 2018;57:1192-200.
DOI
|
| 95 |
Tredget EE, Wang R, Shen Q, et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 2000;20:143-51.
DOI
|
| 96 |
Kinzbrunner B, Ritter S, Domingo J, et al. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer 1983;52:2201-4.
DOI
|
| 97 |
Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 2001;3:111-4.
DOI
|
| 98 |
Grossman E, Messerli FH. Calcium antagonists. Prog Cardiovasc Dis 2004;47:34-57.
DOI
|
webmaster
